These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2053636)

  • 21. Rapid detoxification from opioid dependence.
    Kosten TR; Krystal JH; Charney DS; Price LH; Morgan CH; Kleber HD
    Am J Psychiatry; 1989 Oct; 146(10):1349. PubMed ID: 2675644
    [No Abstract]   [Full Text] [Related]  

  • 22. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 24. Clonidine and opiate withdrawal.
    Gold MS; Pottash AL; Extein I; Kleber HD
    Lancet; 1980 Nov; 2(8203):1078-9. PubMed ID: 6107698
    [No Abstract]   [Full Text] [Related]  

  • 25. The index of choice: indications of methadone patients' selection of naltrexone treatment.
    Singleton EG; Sherman MF; Bigelow GE
    Am J Drug Alcohol Abuse; 1984; 10(2):209-21. PubMed ID: 6475888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and ultrarapid opioid detoxification techniques.
    O'Connor PG; Kosten TR
    JAMA; 1998 Jan; 279(3):229-34. PubMed ID: 9438745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone.
    Kleber HD
    J Subst Abuse Treat; 1985; 2(2):117-22. PubMed ID: 3007777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of opioid withdrawal].
    Cortese S; Risso M
    Vertex; 2008; 19(77):522-6. PubMed ID: 18443666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid dependence.
    Praveen KT; Law F; O'Shea J; Melichar J
    Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term relapse of ultra-rapid opioid detoxification.
    Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
    J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined naloxone/methadone preparations for opiate substitution therapy.
    Loimer N; Presslich O; Grünberger J; Linzmayer L
    J Subst Abuse Treat; 1991; 8(3):157-60. PubMed ID: 1960767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rapid opiate detoxification under anesthesia (RODA)].
    Dubols N; Hallet C; Luppens D; Ansseau M; Charlier C
    Rev Med Liege; 2013; 68(5-6):298-302. PubMed ID: 23888580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrashort noninvasive opiate detoxification.
    Loimer N; Hofmann P; Chaudhry H
    Am J Psychiatry; 1993 May; 150(5):839. PubMed ID: 8480840
    [No Abstract]   [Full Text] [Related]  

  • 35. Searching for a general anaesthesia protocol for rapid detoxification from opioids.
    Lorenzi P; Marsili M; Boncinelli S; Fabbri LP; Fontanari P; Zorn AM; Mannaioni PF; Masini E
    Eur J Anaesthesiol; 1999 Oct; 16(10):719-27. PubMed ID: 10583357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid-dependent error processing.
    Fellows-Smith J
    J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.